SCHEDULE 13D/A: Major Shareholders Divest Significant Stake in Guardian Pharmacy Services

A group of reporting persons, including Bindley Capital Partners I, LLC, have significantly reduced their collective beneficial ownership in Guardian Pharmacy Services, Inc. by selling over 7 million shares.

Summary

• This Schedule 13D Amendment No. 1 reports a significant change in beneficial ownership of Guardian Pharmacy Services, Inc. Class A Common Stock by a group of reporting persons.
• The reporting persons, including Bindley Capital Partners I, LLC, William E. Bindley, Thomas J. Salentine, Jr., Pharmacy Investors, LLC, John Ackerman, Cardinal Equity Fund, L.P., Fred P. Burke, David K. Morris, and G. Kendall Forbes, collectively sold an aggregate of 6,059,553 shares on May 27, 2025.
• Additionally, the underwriters exercised their option in full on May 28, 2025, to purchase an additional 1,125,000 shares from the reporting persons, bringing the total shares divested to 7,184,553.
• As a result of these sales, the collective beneficial ownership of the reporting persons in Guardian Pharmacy Services, Inc. has decreased to 3,385,599 shares, representing approximately 14.9% of the outstanding shares.
• The percentage is calculated based on 22,719,946 shares of Class A Common Stock outstanding as of May 1, 2025, as disclosed in the Issuer's Form 10-Q filed on May 12, 2025.
• In connection with the sale, the reporting persons entered into lock-up agreements for 150 days from May 22, 2025, restricting further sales of the Issuer's common stock or convertible securities without the underwriters' consent.

Sentiment

Score: 3

Explanation: The significant divestment of shares by a group of major reporting persons, totaling over 7 million shares, is generally viewed as a negative indicator of confidence in the company's future prospects by these key stakeholders. While the transaction was orderly and included a lock-up, the sheer volume of shares sold suggests a strategic reduction in exposure.

Positives

• The sale of a large block of shares through an underwriting agreement suggests an orderly market transaction, potentially minimizing immediate downward pressure compared to open market sales.
• The lock-up agreement for 150 days provides a period of stability, preventing further large-scale sales by these reporting persons in the near term.

Negatives

• The reporting persons collectively divested a substantial 7,184,553 shares, significantly reducing their stake in Guardian Pharmacy Services, Inc.
• This large-scale reduction in ownership by a group of major shareholders, from an implied approximately 46.5% to 14.9%, could be perceived by the market as a negative signal regarding the company's future prospects or valuation.

Risks

• The market may interpret the large-scale divestment by significant shareholders as a negative signal, potentially leading to downward pressure on the stock price.
• While a lock-up agreement is in place, the eventual expiration of this 150-day period could lead to renewed selling pressure if the reporting persons decide to further reduce their holdings.

Future Outlook

The document does not contain explicit forward-looking statements or guidance from the company or the reporting persons regarding the company's future performance. It focuses on past share transactions.

Industry Context

This filing is specific to a change in ownership structure for Guardian Pharmacy Services, Inc. and does not provide information to analyze broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Potential negative impact on share price due to the large volume of shares sold and the signal from significant shareholders reducing their stake.
• Company: No direct operational impact mentioned, but the change in ownership structure could influence future strategic decisions or investor relations.

Next Steps

• Expiration of the 150-day lock-up period for the reporting persons, approximately on October 19, 2025 (150 days after May 22, 2025).

Key Dates

Recommendation

Keywords

Guardian Pharmacy Services, Class A Common Stock, Schedule 13D, SEC filing, share sale, beneficial ownership, Bindley Capital Partners, Raymond James, lock-up agreement, equity divestment, institutional selling